<?xml version="1.0" ?><!DOCTYPE rss [<!ENTITY % HTMLlat1 PUBLIC "-//W3C//ENTITIES Latin 1 for XHTML//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml-lat1.ent">]>                                 
<rss version="2.0" xml:base="http://www.brefnet.org">                                                                                                           
<channel>                                                                                                                                                              
 <title>BREFnet.org: News</title>                                                                                                                  
 <link>http://www.brefnet.org/news/all</link>                                                                                                                    
 <description>Updates from BREF</description>                                                                                                     
 <language>en</language>                                                                                                                                               
                                                                                                                                                                       
                                                                                                                                         
                                                                                                                                  
  <item>                                                                                                                                                               
   <title>Zimmer Durom Cup video</title>                                                                                                                  
   <link>http://www.brefnet.org/news/article/30</link>                                                                                                
   <description>An article with a link to the video can be found &lt;br /&gt;
&lt;a href=&quot;http://houston.injuryboard.com/medical-devices-and-implants/surgeons-say-durom-cup-has-flawed-design.aspx?googleid=264486&quot;&gt;here&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;object width=&quot;425&quot; height=&quot;344&quot;&gt;&lt;param name=&quot;movie&quot; value=&quot;http://www.youtube.com/v/j_QjlH0QYYU&amp;hl=en&amp;fs=1&amp;&quot;&gt;&lt;/param&gt;&lt;param name=&quot;allowFullScreen&quot; value=&quot;true&quot;&gt;&lt;/param&gt;&lt;param name=&quot;allowscriptaccess&quot; value=&quot;always&quot;&gt;&lt;/param&gt;&lt;embed src=&quot;http://www.youtube.com/v/j_QjlH0QYYU&amp;hl=en&amp;fs=1&amp;&quot; type=&quot;application/x-shockwave-flash&quot; allowscriptaccess=&quot;always&quot; allowfullscreen=&quot;true&quot; width=&quot;425&quot; height=&quot;344&quot;&gt;&lt;/embed&gt;&lt;/object&gt;</description>                                                                                                
   <pubDate>Wed, 10 Jun 2009 00:00:00 -0400</pubDate>                                                                                                   
  </item>                                                                                                                                                              
                                                                                                                                  
  <item>                                                                                                                                                               
   <title>Zimmer Buys Abbott Spine</title>                                                                                                                  
   <link>http://www.brefnet.org/news/article/29</link>                                                                                                
   <description>This article is of interest to the spinal fusion/ implant device market. Both Zimmer and Abbott are major Orthopedic Implant Manufacturers. &lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://sis.windhover.com/buy/abstract.php?id=2008800157&quot;&gt;InVivio article&lt;/a&gt;.</description>                                                                                                
   <pubDate>Mon, 24 Nov 2008 00:00:00 -0500</pubDate>                                                                                                   
  </item>                                                                                                                                                              
                                                                                                                                  
  <item>                                                                                                                                                               
   <title>Medtronic Probe</title>                                                                                                                  
   <link>http://www.brefnet.org/news/article/28</link>                                                                                                
   <description>&quot;A number of patients say they have been harmed in off-label uses of Infuse, which is approved by the FDA only for a small section of the spine in the lower, lumbar region. At least 280 reports of side effects involving Infuse have been made to the FDA. About three-quarters of those reports involve off-label use. In July, the agency issued a safety alert about complications from the off-label use of Infuse in the neck, or cervical, area of the spine.&quot;&lt;br /&gt;
&lt;br /&gt;
read the full article in the &lt;a href=&quot;http://online.wsj.com/article/SB122706488112540161.html&quot;&gt;wall street journal&lt;/a&gt; or in the associated press:  &lt;a href=&quot;http://www.google.com/hostednews/ap/article/ALeqM5hM8YjGX4rOQoO00bAkCtoj9kvjUwD94I3LQ00&quot;&gt; AP&lt;/a&gt;.</description>                                                                                                
   <pubDate>Wed, 19 Nov 2008 00:00:00 -0500</pubDate>                                                                                                   
  </item>                                                                                                                                                              
                                                                                                                                  
  <item>                                                                                                                                                               
   <title>Thoratec Heart Pump: Recall HeartMate II.</title>                                                                                                                  
   <link>http://www.brefnet.org/news/article/27</link>                                                                                                
   <description>This Thoratec pump has been approved by the FDA just last April and implanted in 1,973 people.  Patients with the device should have it examined.&lt;br /&gt;
&lt;br /&gt;
Read the story: &lt;a href=&quot;http://www.bloomberg.com/apps/news?pid=20601103&amp;sid=aeJMbqsLQZ9U&amp;refer=us&quot;&gt;Bloomberg&lt;/a&gt;</description>                                                                                                
   <pubDate>Tue, 28 Oct 2008 00:00:00 -0400</pubDate>                                                                                                   
  </item>                                                                                                                                                              
                                                                                                                                  
  <item>                                                                                                                                                               
   <title>Catheter Recall</title>                                                                                                                  
   <link>http://www.brefnet.org/news/article/26</link>                                                                                                
   <description>Medtronic has sold some 25,000 catheters of the type discussed in the recall, said spokeswoman Cindy Resman.&lt;br /&gt;
&lt;br /&gt;
Medtronic's drug pumps are implanted in the abdomen and deliver medication through a catheter to the intrathecal space in the spine, the area that surrounds the spinal cord.&lt;br /&gt;
&lt;br /&gt;
&lt;a href=&quot;http://www.twincities.com/business/ci_10567190&quot;&gt;article&lt;/a&gt;</description>                                                                                                
   <pubDate>Fri, 03 Oct 2008 00:00:00 -0400</pubDate>                                                                                                   
  </item>                                                                                                                                                              
                                                                                                                                  
  <item>                                                                                                                                                               
   <title>FDA Brochure on Pediatric Implants</title>                                                                                                                  
   <link>http://www.brefnet.org/news/article/25</link>                                                                                                
   <description>The new handout lists factors to consider, safety concerns, and lists examples of devices commonly implanted in children.  The handout can be found at the FDA website &lt;a href=&quot;http://www.fda.gov/consumer/updates/pediatric_devices091608.html&quot;&gt;here&lt;/a&gt;</description>                                                                                                
   <pubDate>Wed, 17 Sep 2008 00:00:00 -0400</pubDate>                                                                                                   
  </item>                                                                                                                                                              
                                                                                                                                  
  <item>                                                                                                                                                               
   <title>Stenting vs Bypass results from SYNTAX</title>                                                                                                                  
   <link>http://www.brefnet.org/news/article/23</link>                                                                                                
   <description>The primary endpoints of the study were major adverse cardiac and cerebrovascular events. CABG out performed the Taxus stents.  The average number of stents placed in patients was 4.6 inside 3.6 lesions.  &lt;br /&gt;
&lt;br /&gt;
For more results:&lt;br /&gt;
&lt;a href=&quot;http://www.cardiosource.com/clinicaltrials/trial.asp?trialID=1735&quot;&gt;&lt;br /&gt;
ACC article: The Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery. &lt;/a&gt;</description>                                                                                                
   <pubDate>Tue, 02 Sep 2008 00:00:00 -0400</pubDate>                                                                                                   
  </item>                                                                                                                                                              
                                                                                                                                  
  <item>                                                                                                                                                               
   <title>UK Registry shows problems with new joints</title>                                                                                                                  
   <link>http://www.brefnet.org/news/article/24</link>                                                                                                
   <description>Almost twice as many patients (2.8 %) receiving unicompartmental knee replacement had to have revision surgery in 3 years.  1.4% of patients with traditional total knee replacement needed revision. Similarly, hip resurfacing was not as long lasting as replacement.&lt;br /&gt;
&lt;br /&gt;
For more information:&lt;br /&gt;
&lt;a href=&quot;http://www.telegraph.co.uk/news/uknews/2663548/New-hip-and-knee-replacements-more-likely-to-need-repeat-surgery.html&quot;&gt;Telegraph article&lt;/a&gt;</description>                                                                                                
   <pubDate>Tue, 02 Sep 2008 00:00:00 -0400</pubDate>                                                                                                   
  </item>                                                                                                                                                              
                                                                                                                                                   
                                                                                                                                                        
                                                                                                                                                                       
</channel>                                                                                                                                                             
</rss>